Broadcom Q2: Why The FY27 $100B Target May Already Be Obsolete

The key takeaway is not just that AVGO’s AI narrative is intact, but that the market may still be underestimating the convexity in backlog conversion. If April-only contracts already imply a 2027 runway that can support or exceed the current revenue target, the bigger surprise into the June 3 print is likely a step-up in forward visibility rather than a one-quarter beat. That matters because the stock is still being priced like a hardware beneficiary, when this pattern increasingly resembles a long-duration infrastructure platform with multi-year contracted cash flows.

Second-order winners are the ecosystem names that consume or integrate this capacity: GOOGL and META are effectively signaling that AI compute remains a strategic priority even as capex scrutiny rises. The duration of those commitments reduces the probability of an abrupt hyperscaler capex reset over the next 2-3 quarters, which should support the broader AI complex and custom silicon supply chain. The less obvious loser is any merchant accelerator or networking vendor relying on spot demand; the more demand is locked into AVGO-style bespoke supply, the less room there is for price competition outside committed capacity.

The risk is not demand cancellation, but digestion: after the June print, investors may extrapolate too aggressively and bid the stock ahead of the actual guide revision, leaving room for a sell-the-news reaction if management only confirms rather than raises. A second risk is that backlog quality matters as much as size—if later-stage deployment timing slips into 2028, the headline revenue floor remains intact but near-term multiple expansion could stall. BAC is only indirectly relevant here as a read-through on consensus framing and sell-side model revisions, not as a fundamental driver.

Contrarian view: the market may be too focused on AVGO’s top-line upside and not enough on margin durability. If AI revenue becomes more contracted and less cyclical, the debate shifts from order growth to mix, pricing power, and gross margin normalization; that can cap upside even as revenues surprise. In that scenario, the better asymmetry may be relative value long AVGO versus short a basket of AI beneficiaries with less visible contracted demand and more execution risk.